AI assistant
Sending…
Evogene Ltd. — Report Publication Announcement 2022
Nov 14, 2022
6785_rns_2022-11-14_d78296bd-00ee-4e20-bdf1-6893801d6994.htm
Report Publication Announcement
Open in viewerOpens in your device viewer
_________ false
| ����� ��"� | 2 381 |
| EVOGENE LTD | |
| Corporation no: 512838723 | 14299 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C003 ( Public ) | Reported via MAGNA: | 14/11/2022 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2022-02-136594 | Time of broadcast: 13:02 13:02 |
Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on | Lavie Bio Investor Presentation |
LavieBioPPT_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 02/11/2022 |
| Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724 | |
| E-mail address: [email protected] Company site: www.evogene.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Deutsch Nitsan Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company: | |
| Address: Gad Feinstein 13 , Rehovot 7638517 Telephone: 08-9311900 Facsimile: 08-9466724 E-mail: [email protected] 1 | |
More from Evogene Ltd.
Report Publication Announcement
2026
Jun 2
Regulatory Filings
2026
Jun 2
Report Publication Announcement
2026
May 20
Share Issue/Capital Change
2026
May 20
Earnings Release
2026
May 20
Report Publication Announcement
2026
May 20
Capital/Financing Update
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Report Publication Announcement
2026
May 18